Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.31.1 (
micrococcal nuclease
)
2,818
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Fas ligand
(FasL/CD95L/
TNFSF6
), a member of the tumor necrosis factor family, initiates apoptosis in lymphoid and nonlymphoid tissues by binding to its receptor Fas (CD95/TNFRSF6). Although the transcriptional control of
TNFSF6
gene expression is subjected to intense study, the role of its chromatin organization and accessibility to the transcriptional machinery is not known. Here, we determined the chromatin organization of
TNFSF6
gene 5' regulatory regions. Using the indirect end-labeling technique, a unique region named HSS1 and encompassing nucleotides -189 to +185 according to the transcriptional start site, was identified throughout a 20-kilobase nucleosomal DNA domain surrounding the promoter. The HSS1 region displayed hypersensitivity to in vivo DNase I digestion in
TNFSF6
-expressing cells only, including upon T cell activation. Hypersensitivity to
micrococcal nuclease
digestion and to specific restriction enzyme digestion suggested the precise positioning of two nucleosomes across the transcription start site and minimal promoter region, likely interfering with
TNFSF6
active transcription in T lymphocytes. Indeed, HSS1 hypersensitivity to nuclease digestion strictly correlated with
TNFSF6
transcription, including in primary and leukemia T cells. HSS1 chromatin remodeling preceded detectable
TNFSF6
mRNA accumulation and was blocked by cycloheximide that also prevented
TNFSF6
transcription. However, DNA methylation levels of the
TNFSF6
HSS1 region did not correlate with transcriptional activation. Induction of global protein acetylation by treatment with histone deacetylase inhibitors was not accompanied by HSS1 chromatin remodeling and/or
TNFSF6
transcription. We conclude that chromatin remodeling is a primary event in the activation of
TNFSF6
expression in primary and leukemia T cells and that mechanisms independent of protein deacetylation and of DNA methylation of the
TNFSF6
promoter region are involved in the repression of
TNFSF6
gene expression.
...
PMID:Active transcription of the human FASL/CD95L/TNFSF6 promoter region in T lymphocytes involves chromatin remodeling: role of DNA methylation and protein acetylation suggest distinct mechanisms of transcriptional repression. 1659 63